Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Naveed Sattar

67PUBLICATIONS
223CO-AUTHORS
Nutrigenomics and personalised nutritionMedical parasitologyCardiology (incl. cardiovascular diseases)Other Asian languages (excl. South-East Asian)Nanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

Sort by Publication Date:
|May 20, 2026
Response to Comment on Mann et al. Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257-265.

|Apr 06, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Naveed Sattar, Hertzel C Gerstein, David D'Alessio

|Jan 22, 2026
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.

Ayodele Odutayo, Deepak L Bhatt, Vikas S Sridhar

|Aug 20, 2025
Response to Comment on Lee et al. Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity. Diabetes Care 2025;48:489-493.

Matthew M Y Lee, Darren K McGuire, Naveed Sattar

|Jul 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.

Robert F Storey, John Deanfield, Stefan James

|May 12, 2025
The Association Between Tirzepatide Versus Insulin Glargine and NT-proBNP Levels in People With Type 2 Diabetes With or at Elevated Risk for Cardiovascular Disease: Post hoc Analyses of SURPASS 4.

Naveed Sattar, Govinda J Weerakkody, Darren K McGuire

Pageof 12

Frequent Collaborators

14 joint publications

Naveed Sattar

8 joint publications

Deepak L Bhatt

8 joint publications

Ambarish Pandey

7 joint publications

David Z I Cherney

7 joint publications

Silvio E Inzucchi

6 joint publications

Christopher P Cannon

6 joint publications

Ahmed A Kolkailah

6 joint publications

Lawrence A Leiter

5 joint publications

John B Buse

5 joint publications

Itamar Raz

Frequent Collaborators

14 joint publications

Naveed Sattar

8 joint publications

Deepak L Bhatt

8 joint publications

Ambarish Pandey

7 joint publications

David Z I Cherney